Home Patient Resources Commitment to Safety About Investors For U.S. Surgeons SEE A COLLABORATION COMMITTED TO SAFETY AND INNOVATION As part of Sientra’s commitment to safety and innovation, Sientra is collaborating with Butterfly to provide board-certified plastic surgeons with enhanced diagnostic tools and education for proactive surveillance of breast implant outcomes.1 Butterfly has developed the world’s only single-probe, whole-body ultrasound system that connects to a mobile device to transform care delivery and improve efficiencies. see immediate results IN YOUR HANDS BUY NOW The addition of ultrasound in my practice has been a game-changer not only in the evaluation of breast implants but in communicating with patients about their implants. Patients are eager to have ultrasound evaluations of their implants. The Butterfly iQ+ has excellent resolution, is portable and can be attached to any phone. – MELINDA HAWS, MD, F.A.C.S. Board-Certified Plastic Surgeon Sientra Advisory Board Member see the possibilities FOR YOUR PRACTICE 51:19 contact us to learn more view icon shop Butterfly iQ+ view icon connect with us Group 3 Group 8 Group 9 SCROLL TO TOP REFERENCES: 1. Current FDA Recommendations on Rupture Screening include: For asymptomatic patients, the first ultrasound or magnetic resonance imaging (MRI) should be performed at 5-6 years postoperatively, then every 2-3 years thereafter. For symptomatic patients or patients with equivocal ultrasound results for rupture at any time postoperatively, an MRI is recommended. For more information: https://www.fda.gov/media/131885/download IMPORTANT SAFETY INFORMATION: Sientra breast implants are indicated for breast augmentation in women at least 22 years old and for breast reconstruction. Breast implant surgery is contraindicated in women with active infection anywhere in their body, with existing cancer or precancerous conditions who have not received adequate treatment for those conditions, and who are currently pregnant or nursing. Prior to use, plastic surgeons should review all risk information, which is found in the Directions for Use. Key complications associated with the use of silicone gel breast implants include capsular contracture, implant removal, rupture, and reoperation. The Directions for Use and detailed information regarding the risks and benefits of Sientra breast implants can be found at sientra.com. Butterfly iQ+ is Rx only (USA). For use by qualified and trained healthcare practitioners. Sientra® is a trademark of Sientra, Inc. Butterfly™ and IQ+™ are trademarks of Butterfly Network, Inc. ©2021 Sientra, Inc. All rights reserved. MDC-0664 R1 PRIVACY STATEMENT TERMS OF USE SAFETY COMPLIANCE RESOURCES PATENTS CONTACT US CAREERS © 2021 Sientra, Inc. All rights reserved. This website uses cookies and other technologies to enhance site navigation, analyze site usage and assist in marketing efforts . You may find out more about our use of cookies in our Privacy Statement here. By continuing to use this site you accept our use of cookies. Learn more Got it!